WARRANT TO PURCHASE SHARES OF CAPITAL STOCKWarrant Agreement • August 15th, 2012 • Q Holdings, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 15th, 2012 Company Industry JurisdictionTHIS CERTIFIES THAT, for value received, ________________ or his registered assigns (the “Holder”), is entitled, subject to the provisions and upon the terms and conditions set forth herein, to purchase from Q THERAPEUTICS, INC., a Delaware corporation (the “Company”), Shares (as defined below) in the amounts, at such times and at the price per share set forth in Section 1. The term “Warrant” as used herein shall include this Warrant and any warrants delivered in substitution or exchange therefor as provided herein. This Warrant is issued in connection with the transactions described in the Note and Securities Purchase Agreement, dated as of August 30, 2011, by and between the Company and the parties thereto (the “Purchase Agreement”), pursuant to which the original Holder was issued a convertible promissory note (the “Note”) in the principal amount set forth in the Purchase Agreement.
AMENDMENT TO STOCK PURCHASE WARRANTStock Purchase Warrant • August 15th, 2012 • Q Holdings, Inc. • Pharmaceutical preparations • Utah
Contract Type FiledAugust 15th, 2012 Company Industry JurisdictionThis Amendment to Stock Purchase Warrant (this “Amendment”) is made and entered into as of October 13, 2011, by and between Q Holdings, Inc. (formerly known as Grace 2, Inc.), a Delaware corporation (the “Parent”), Q Therapeutics, Inc., a Delaware corporation (the “Company”), and _________________, (the “Warrant Holder”). Capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Warrant Agreement (as defined below).